Singapore-based AI and automation startup Galatek has successfully closed a US$30 million Series A funding round, marking a significant milestone in its growth trajectory. This substantial investment is set to fuel the company's expansion in the life sciences and advanced semiconductor manufacturing sectors. The capital will be strategically deployed to accelerate product development, enhance its global supply chain, and grow its international teams across key markets.
Pioneering a New Era in Life Sciences
Galatek is at the forefront of creating the smart laboratory of the future, addressing critical challenges within the life sciences industry. The company integrates artificial intelligence into research and development workflows to accelerate discovery in areas like diagnostics, drug development, and synthetic biology. Its proprietary Abio software platform unifies lab management systems, transforming scientific data into actionable insights and streamlining robotic integrations.
This innovative approach empowers scientists to de-risk complex applications, including next-generation sequencing and 3D cell culture. To achieve this, Galatek has forged strategic partnerships with top-tier global pharmaceutical firms and renowned research institutions. Its collaboration with the National University of Singapore to co-create next-generation smart labs exemplifies its commitment to sustained technology leadership.
Advancing Semiconductor Manufacturing
In the semiconductor industry, Galatek is driving innovation in advanced packaging through its sophisticated AI-powered solutions. The company leverages a deep integration of vision AI and motion control algorithms to meet extreme demands for precision and reliability. Its offerings include critical process equipment such as fully automated overlay measurement systems and deep learning-based automatic optical inspection (AOI) systems.
These technologies provide essential solutions for both front-end metrology and back-end advanced packaging processes, addressing key industry needs. Galatek is actively collaborating with several leading global semiconductor manufacturers, showcasing its end-to-end commercialization capabilities. This demonstrates the company's ability to move from technological breakthroughs to scaled delivery in a highly competitive market.
A Global Strategy with Localized Execution
The company's operational strength is built on a unique 'Global Supply Chain + Localized Service' business model. This strategy combines the competitive advantages of Asian supply chains with company-owned delivery centers in Malaysia and the United States. This structure creates a resilient and agile global logistics network capable of meeting diverse and evolving client needs worldwide.
To complement its robust supply chain, Galatek maintains dedicated local teams in key markets across Europe, North America, and Southeast Asia. These teams provide proactive and customized support throughout the entire customer journey, from initial sales to technical service and compliance. This ensures clients receive a seamlessly integrated and responsive offering tailored to their specific regional requirements.
Leadership's Vision for Industrial Transformation
According to CEO David Tian, the global industry is undergoing a fundamental transformation driven by artificial intelligence and automation. He emphasized that Galatek's mission is to serve as a reliable infrastructure partner in this evolution. The company focuses on critical junctures in smart laboratories and semiconductor packaging where innovation is most urgently needed.
Tian stated that by combining world-class supply chain capabilities with local resources, the company can deliver innovative solutions more rapidly than traditional providers. He expressed confidence that this Series A funding will accelerate Galatek's journey to fulfill this crucial role at a global scale. The investment validates the company's strategic direction and its potential for significant market impact.
With its newly secured US$30 million in funding, Galatek is poised for significant growth and market leadership in high-tech industries. The investment will bolster its efforts to innovate in the high-demand sectors of life sciences and semiconductor manufacturing. By addressing key technology gaps with its unique blend of AI, automation, and a global-local service model, Galatek is strategically positioned as an essential enabler of industrial progress.